Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 433-444 of 6042

Figure 1. DAZALS exploratory overall survival analysis at one-year – patients who received 300 mg of dazucorilant compared to patients who received only placebo.

Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting

Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance

Business Wire logo

UPMC Ireland Selects MEDITECH Expanse as the Cornerstone of its Digital Strategy

Sectra's year-end report 2024/2025: Reporting solid growth in a time of change

Business Wire logo

Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research

PR Newswire associated0

Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany

PR Newswire associated0

Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities

PR Newswire associated0

Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting

Business Wire logo

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

Dr. Matthias Preusser during Oral Presentation of TUXEDO-3 at ASCO 2025

New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options

Dr. Benjamin Chien founder and CEO of QPS Holdings, LLC.

QPS Celebrates 30th Anniversary

  • Prev Page
  • 1
  • 2
  • …
  • 36
  • 37
  • 38
  • …
  • 503
  • 504
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us